The board of directors of Consun Pharmaceutical Group Limited announced that, on 17 January 2019, the Group entered into a strategic cooperation framework agreement with the School of Medicine, South China University of Technology. In accordance with the Strategic Cooperation Agreement, the Parties agreed to cooperate in various areas, including but not limited to the following: Establish "Consun-SCUT Research Centre for Medical Imaging": The Parties will gradually establish a technologic innovation system covering three levels, the basic level, the technical level and the application level in the scientific research and application areas of medical imaging in accordance with the development strategy of "leading in application, breakthrough of basic aspects, and synergic development" based on their respective advantages so as to jointly build a research centre for medical imaging. Establish a joint-research and development and achievements sharing mechanism: The Parties shall cooperate and work together in medical-related areas, to jointly apply for projects funded by national and provincial government and awards for achievements in scientific research in the PRC, publish research papers together, and share achievements in scientific research and intellectual properties (including but not limited to patents). The Group can have the priority to choose achievements in scientific research to carry out industrial operations. The Parties shall share the revenue generated from industrial operations based on the market by way of, including but not limited to, transfer of or investment in achievements in scientific research, sales revenue or profit-sharing. The Strategic Cooperation Agreement is entered into by the Parties as a framework for their long-term cooperation. Further contracts will be entered into by the Parties in relation to each specific business under the Strategic Cooperation Agreement, setting out the subject matters of cooperation as well as rights and obligations of the Parties.